Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Nuvalent, Inc. (NUVL) insider trading activity

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is > 10% Shareholder of Nuvalent, Inc.. Currently has a direct ownership of 897,671 shares of NUVL, which is worth approximately $66.9 Million. The most recent transaction as insider was on Aug 02, 2021, when has been sold 897,671 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 898K

0% 3M change

0% 12M change

Total Value Held $66.9 Million

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 02 2021	BUY Conversion of derivative security	-	897,671 Added 50.0%	897,671 Class A Common Stock

Also insider at

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

OLMA

Olema Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

EWTX

Edgewise Therapeutics, Inc. Healthcare

> 10% Shareholder

VERV

Verve Therapeutics, Inc. Healthcare

> 10% Shareholder

ACRV

Acrivon Therapeutics, Inc.

BOLD

Boundless Bio, Inc.

WBI